Influencing factors and risk prediction model for cervical cancer recurrence
- PMID: 36748382
- PMCID: PMC10930263
- DOI: 10.11817/j.issn.1672-7347.2022.210722
Influencing factors and risk prediction model for cervical cancer recurrence
Abstract
Objectives: Cervical cancer is the most common malignant tumor in the female reproductive system worldwide. The recurrence rate for the treated cervical cancer patients is high, which seriously threatens women's lives and health. At present, the risk prediction study of cervical cancer has not been reported. Based on the influencing factors of cervical cancer recurrence, we aim to establish a risk prediction model of cervical cancer recurrence to provide a scientific basis for the prevention and treatment of cervical cancer recurrence.
Methods: A total of 4 358 cervical cancer patients admitted to the Hunan Cancer Hospital from January 1992 to December 2005 were selected as research subjects, and the recurrence of cervical cancer patients after treatment was followed up. Univariate analysis was used to analyze the possible influencing factors. Variables that were significant in univariate analysis or those that were not significant in univariate analysis but may be considered significant were included in multivariate Cox regression analysis to establish a cervical cancer recurrence risk prediction model. Line graphs was used to show the model and it was evaluated by using receiver operating characteristic (ROC) curves, calibration plots, and decision curve analysis.
Results: Univariate analysis showed that the recurrence rates of cervical cancer patients with different age, age of menarche, parity, miscarriage, clinical stage, and treatment method were significantly different (all P<0.05). Multivariate Cox regression analysis showed that RR=-0.489×(age≥55 years old)+0.481×(age at menarche >15 years old)+0.459×(number of miscarriages≥3)+0.416×(clinical stage II)+0.613×(clinical stage III/IV)+0.366×(the treatment method was surgery + chemotherapy) + 0.015×(the treatment method was chemotherapy alone). The area under the ROC curve (AUC) of the Cox risk prediction model for cervical cancer recurrence constructed was 0.736 (95% CI 0.684 to 0.789), the best prediction threshold was 0.857, the sensitivity was 0.576, and the specificity was 0.810. The accuracy of the Cox risk model constructed by this model was good. From the clinical decision curve, the net benefit value was high and the validity was good.
Conclusions: Patient age, age at menarche, miscarriages, clinical stages, and treatment methods are independent factors affecting cervical cancer recurrence. The Cox proportional hazards prediction model for cervical cancer recurrence constructed in this study can be better used for predicting the risk of cervical cancer recurrence.
目的: 宫颈癌是全球女性生殖系统中最常见的恶性肿瘤,治疗后的宫颈癌患者复发率高,严重威胁妇女的生命健康。目前尚未见有关宫颈癌复发风险预测的研究报道。本研究基于宫颈癌复发的影响因素,建立宫颈癌复发风险预测模型,为宫颈癌复发防治提供科学依据。方法: 选择1992年1月至2005年12月湖南省肿瘤医院收治的4 358例宫颈癌患者为研究对象,随访宫颈癌患者治疗后的复发情况。对其可能的影响因素进行单因素分析,将单因素分析有统计学意义或单因素分析无统计学意义但专业上认为可能有意义的变量纳入多元Cox回归分析,建立宫颈癌复发风险预测模型,预测模型通过列线图展示。采用受试者工作特征(receiver operating characteristic,ROC)曲线、一致性曲线和临床决策曲线对模型进行评价。结果: 单因素分析显示:不同年龄、初潮年龄、生产次数、流产次数、临床分期和治疗方式的宫颈癌患者复发率比较,差异均有统计学意义(均P<0.05)。多因素Cox回归分析显示: RR=-0.489×(年龄≥55岁)+0.481×(初潮年龄>15岁)+0.459×(流产次数≥3)+0.416×(临床II期)+0.613×(临床III/IV期)+0.366×(治疗方式为手术+化学治疗)+0.015×(治疗方式为单纯化学治疗)。本研究构建的宫颈癌复发Cox风险预测模型曲线下面积为0.736(95% CI:0.684~0.789),最佳预测阈值为0.857,灵敏度为0.576,特异度为0.810。从临床决策曲线看净获益值较高,有效性良好。结论: 患者年龄、初潮年龄、流产次数、临床分期和治疗方式是影响宫颈癌复发的独立因素,本研究构建的宫颈癌复发Cox比例风险模型可较好地预测宫颈癌复发的风险。.
Keywords: Cox regression; c ervical cancer recurrence; influencing factors; risk prediction model.
Conflict of interest statement
作者声称无任何利益冲突。
Figures
References
-
- 刘宗超, 李哲轩, 张阳, 等. 2020全球癌症统计报告解读[J]. 肿瘤综合治疗电子杂志, 2021, 7(2): 1-14. 10.12151/JMCM.2021.02-01. - DOI
- LIU Zongchao, LI Zhexuan, ZHANG Yang, et al. Interpretation on the report of global cancer statistics 2020[J]. Journal of Multidisciplinary Cancer Management (Electronic Version), 2021, 7(2): 1-14. 10.12151/JMCM.2021.02-01. - DOI
-
- 王宁, 刘硕, 杨雷, 等. 2018全球癌症统计报告解读[J]. 肿瘤综合治疗电子杂志, 2019, 5(1): 87-97. 10.12151/JMCM.2019.01-10. - DOI
- WANG Ning, LIU Shuo, YANG Lei, et al. Interpretation on the report of global cancer statistics 2018[J]. Journal of Multidisciplinary Cancer Management. Electronic Version, 2019, 5(1): 87-97. 10.12151/JMCM.2019.01-10. - DOI
-
- 李超, 姚莉, 宗玲, 等. 晚期宫颈癌治疗进展[J]. 安徽医科大学学报, 2021, 56(3): 501-504. 10.19405/j.cnki.issn1000-1492.2021.03.034. - DOI
- LI Chao, YAO Li, ZONG Ling, et al. Treatment advances in advanced cervical cancer[J]. Journal of Anhui Medical University, 2021, 56 (3): 501-504. 10.19405/j.cnki.issn1000-1492.2021.03.034. - DOI
